Sputtr.com | Alternative Search Engine

Neurosearch

the blood-brain-barrier by EC Biodelivery

Extensive commercial and academic cooperation With a background at NeuroSearch, a cooperation with both academia and commercial partners is quite obvious to Teit E. Johansen.

List of speakers at the annual meeting 21-22 Jan. 2010

... in a clinical biochemical laboratory - routine and research Jørgen Hasselstrøm , Århus Universitetshospital, Risskov Cereal proteomics. from 2D spot patterns to quality and 3D structures Birthe Svensson , DTU Systembiologi, Enzyme and Protein Chemistry To be announced René Egebro Jensen , Neurosearch ...

Catamount Research & Development Chroma Technology Merck ...

Invited Speaker/Abstract Author Disclosures: Smooth Muscle Jensen, Julie NeuroSearch A/S 2, 3 11803-081 Speakers not listed above have indicated there are not any conflicts to disclose.

Ballerup, Denmark, August 10th, 2010

For further information please contact: Teit E. Johansen, President & CEO Telephone: +45 44 60 89 48; Fax: +45 44 60 89 89 E-mail: tej@nsgene.dk NsGene A/S Background NsGene A/S (www.nsgene.dk) is a privately held Danish biotechnology company founded in 1999 as a spin-off from NeuroSearch A/S [OMX Nordic ...

DR Pipeline Report NEUROLOGY PIPELINE ANALYSIS: TOP COMPANIES ...

NeuroSearch’s Alliances in the Neurology Area (1999-2003) . . . . . . . . . . . 81 Table 35. NeuroSearch’s Financial Information, 1998-2002 .

Jefferies 2011 Global Healthcare Conference

NeuroSearch A/S (CPSE:NEUR) POZEN, Inc. (POZN) Managed Care – Richard Barasch, Chairman & CEO: Life Science Tools – Cliff Reid, President & CEO

13:00 - 13:15 Welcome by Lars Friis Mikkelsen, Chair of the ...

... 20 Berit Christoffersen, Novo Nordisk: Artherosclerosis animal models 14:20 - 14:45 Kirsten Dahl, Novo Nordisk: A 3R approach to optimised use of large animal metabolic animal models Ethical committees Chair: Karin Kold, University of Copenhagen, Faculty of Life Sciences Alexander Norup Nielsen, NeuroSearch ...

Pipeline Gaps back to table of contents Can biotech fill them?

NeuroSearch will receive a total of 82 million in guaranteed payments. On signing the agreement, NeuroSearch will receive E46.8 million, comprising 29.1 million of up-front and research payments, and 17.7 million for 616,000 new NeuroSearch shares to be

Product Development Pipeline

... February 2010 Company Disease Area Phase anti-bacterial inflammatory disease* HIV (protease inhibitor) autoimmune disease neuroscience (anxiety & pain) oncology neuroscience respiratory gastrointestinal l l&ll l l l l l l l Anacor Pharmaceuticals ChemoCentryx Concert Pharmaceuticals Galapagos NeuroSearch OncoMed ...

Sophion and Hydra Establish a Unique Reference Site for ...

Sophion Bioscience A/S was founded in July 2000, emerging from a successful research and development program at NeuroSearch, QPatch 16 is an automated patch clamp system that provides high-quality patch clamp data on a truly industrial basis.